Relitegatide
Relitegatide is a selective αvβ6 integrin-binding peptide. Relitegatide functions as the αvβ6-binding building block of the trimeric PET probe Trivehexin. Relitegatide can be used for research on pancreatic ductal adenocarcinoma (PDAC).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2708163-13-5
- 화학식: C51H75N13O13
- 분자량:1078.22
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Radionuclide-Drug Conjugates (RDCs) Isoforms
More
Biological Activity
제품 설명
IC50 & Target
[1]|
αvβ6 |
RDC Peptide |
Chemical Information
-
CAS No. 2708163-13-5
-
분자량 1078.22
-
화학식 C51H75N13O13
-
Sequence
c[Tyr-Arg-Gly-Asp-Leu-Ala-Tyr-DPro-(NMe)Lys]
-
Sequence Shortening
c[YRGDLAY-DPro-(NMe)K]
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Quigley NG, et al. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin. Eur J Nucl Med Mol Imaging. 2022;49(4):1136-1147. [Content Brief]
[2]. Zhang X, et al. Design, Synthesis, and Biological Evaluation of [18F]AlF-Labeled Integrin αvβ6-Targeting Tracers for Pancreatic Cancer Imaging. J Med Chem. 2025 Jul 10;68(13):14028-14040. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)